BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/2/2015 12:20:00 PM | Browse: 1043 | Download: 1161
Publication Name World Journal of Hepatology
Manuscript ID 12268
Country/Territory China
Received
2014-06-29 13:40
Peer-Review Started
2014-07-01 08:33
To Make the First Decision
2014-07-29 11:59
Return for Revision
2014-07-30 13:36
Revised
2014-08-04 20:08
Second Decision
2014-09-10 09:10
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-09-10 09:36
Articles in Press
2014-09-10 09:36
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-09-30 16:16
Publish the Manuscript Online
2014-10-19 20:39
ISSN 1948-5182 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Surgery
Manuscript Type Minireviews
Article Title Nucleos(t)ide analogues to treat hepatitis B virus-related hepatocellular carcinoma after radical resection
Manuscript Source Invited Manuscript
All Author List Yang Ke, Lin Wang, Le-Qun Li and Jian-Hong Zhong
Funding Agency and Grant Number
Corresponding Author Jian-Hong Zhong, MD, PhD, Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, He Di Rd. #71, Nanning 530021, Guangxi Zhuang Autonomous Region, China. zhongjianhong66@163.com
Key Words Antiviral therapy; Hepatitis B virus; Hepatocellular carcinoma; Liver resection; Nucleos(t)ide analogue; Survival rate
Core Tip Significant advances have been made in nucleos(t)ide analogue (NA) therapy to treat chronic hepatitis B. However, for patients undergoing radical resection for hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC), a number of important questions remain undefined, including when NA therapy should be initiated, how long the treatment should continue, and whether NAs can prevent recurrence after radical resection. Here we review the available evidence on these questions in the Medline database. We focus on NA treatment indications, duration, effects on recurrence-free survival and overall survival, and management of NA resistance in patients with HBV-related HCC.
Publish Date 2014-10-19 20:39
Citation Ke Y, Wang L, Li LQ, Zhong JH. Nucleos(t)ide analogues to treat hepatitis B virus-related hepatocellular carcinoma after radical resection. World J Hepatol 2014; 6(9): 652-659
URL http://www.wjgnet.com/1948-5182/full/v6/i9/652.htm
DOI http://dx.doi.org/10.4254/wjh.v6.i9.652
Full Article (PDF) WJH-6-652.pdf
Full Article (Word) WJH-6-652.doc
Manuscript File 12268-Review.docx
Answering Reviewers 12268-Answering reviewers.pdf
Copyright License Agreement 12268-Copyright assignment.pdf
Peer-review Report 12268-Peer review(s).pdf
Scientific Misconduct Check 12268-CrossCheck.jpg
Scientific Editor Work List 12268-Scientific editor work list.pdf